RxDoctor Payments Data

Edward Barr, MD

Family Medicine · Minerva, OHNPI 1619978723

Payments from drug & device makers

$4,841in general payments, 2019–2025

Across 332 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$662
  • AbbVie$650
  • AstraZeneca$481
  • Lilly USA, LLC$459
  • GSK$361
  • Boehringer Ingelheim$240
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$4,825100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,841 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$86,638
Medicare patients
257
Services billed
1,336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine29$218,463
EliquisApixaban500$198,585
JardianceEmpagliflozin342$174,407
Trelegy ElliptaFluticasone/Umeclidin/Vilanter78$54,919
TrulicityDulaglutide40$43,824
XareltoRivaroxaban64$34,222
OzempicSemaglutide14$34,039
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr66$33,201
Breo ElliptaFluticasone/Vilanterol36$19,316
JanuviaSitagliptin Phosphate34$17,695
GlatopaGlatiramer Acetate25$17,578
AbrysvoRsv Vacc, Pref A And Pref B/Pf56$17,509
FetzimaLevomilnacipran Hcl64$16,648
EntrestoSacubitril/Valsartan40$16,588
Divalproex Sodium222$15,119

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$60$218,46329 claims
PfizerEliquis, Abrysvo$662$216,094556 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$240$197,240393 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$361$113,172197 claims
Lilly USA, LLCTrulicity$459$43,82440 claims
Johnson & JohnsonXarelto$215$34,22264 claims
Novo NordiskOzempic$111$34,03914 claims
MerckJanuvia$221$17,69534 claims
AbbVieFetzima$650$16,64864 claims
NovartisEntresto$69$16,58840 claims
AstraZenecaFarxiga$481$13,60713 claims
Avanir Pharmaceuticals, Inc.Nuedexta$26$13,07819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Minerva

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →